Presenter: Alicia Bigelow, ND
Original Date: July 21 2024

In this lecture, Dr Bigelow will delve into the therapeutic application of IV ketamine in populations where its use requires special consideration, such as in women with postpartum depression, and individuals with alcohol use disorder. Attendees will gain insights into the unique factors to consider when treating members of these populations and how IV ketamine therapy can be tailored to address their specific needs. Through a blend of clinical case studies, empirical evidence, and practical considerations, this session will provide a comprehensive overview of IV ketamine's efficacy, safety, and role in optimizing mental health outcomes across several special populations

NUNM is accredited by the North American Naturopathic Continuing Education Council (NANCEAC). This activity qualifies for 1.5 Pharmacology CEUs.